KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 112 filers reported holding KYMERA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,845,441 | -63.8% | 204,708 | -40.1% | 0.00% | -50.0% |
| Q2 2023 | $7,852,120 | -10.7% | 341,545 | +15.1% | 0.00% | 0.0% |
| Q1 2023 | $8,795,458 | +4.3% | 296,843 | -12.2% | 0.00% | 0.0% |
| Q4 2022 | $8,434,733 | +15.1% | 337,930 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $7,331,000 | +34.3% | 336,759 | +21.5% | 0.00% | +100.0% |
| Q2 2022 | $5,459,000 | -47.1% | 277,264 | +13.7% | 0.00% | -50.0% |
| Q1 2022 | $10,323,000 | -39.3% | 243,926 | -8.9% | 0.00% | -33.3% |
| Q4 2021 | $17,002,000 | +60.6% | 267,790 | +48.6% | 0.00% | +50.0% |
| Q3 2021 | $10,585,000 | +172.7% | 180,207 | +125.3% | 0.00% | +100.0% |
| Q2 2021 | $3,881,000 | +589.3% | 80,003 | +451.9% | 0.00% | – |
| Q1 2021 | $563,000 | -67.5% | 14,496 | -48.1% | 0.00% | – |
| Q4 2020 | $1,732,000 | -63.7% | 27,930 | -81.1% | 0.00% | -100.0% |
| Q3 2020 | $4,773,000 | – | 147,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 639,059 | $37,538,000 | 24.22% |
| BVF INC/IL | 3,180,658 | $186,832,000 | 7.29% |
| Deer IX & Co. Ltd. | 615,895 | $36,178,000 | 3.72% |
| Asymmetry Capital Management, L.P. | 89,071 | $5,232,000 | 3.14% |
| Redmile Group, LLC | 2,793,708 | $164,102,000 | 2.86% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,260 | $21,103,000 | 1.77% |
| CLOUGH CAPITAL PARTNERS L P | 271,000 | $15,919,000 | 0.96% |
| Rock Springs Capital Management LP | 732,927 | $43,052,000 | 0.90% |
| Eagle Health Investments LP | 37,000 | $2,173,000 | 0.69% |
| Avidity Partners Management LP | 514,500 | $30,222,000 | 0.67% |